Related Experiment Video
Updated: Jan 19, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
Consensus best practice pathway of the UK scleroderma study group: gastrointestinal manifestations of systemic
Navjyot Hansi1, Nora Thoua, Maresa Carulli
1Royal Free Hospital, London, UK. nkh174@hotmail.com.
Abstract:
Systemic sclerosis is an autoimmune connective tissue disorder, which can be progressive with multisystem involvement. Guidance on the management of complications is based on a limited data set and practice amongst clinicians can vary. The UK Scleroderma study group set up several working groups to agree some consensus pathways for the management of specific complications. Approximately nine out of ten patients with systemic sclerosis will have involvement of the gastrointestinal system and in this review article we explore the management of these complications in a symptom-based approach. The algorithms are a useful tool for clinicians, which we hope, will be a point of reference and highlight the need for further research in these areas.
Related Concept Videos
Hypertension III: Clinical Manifestations and Diagnostic Studies
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Aneurysm II: Clinical Manifestations and Diagnostic Studies
04:44Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
11:35The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool
08:15Gastrointestinal Motility Monitor (GIMM)

